Adial Pharmaceuticals Aktie 128769662 / US00688A2050
1.11
USD
0.05
USD
4.72%
03.12.2024
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Adial Pharmaceuticals Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | Adial Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
| 2022 | Adial Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
| 2021 | Adial Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
| 2020 | Adial Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
| 2019 | Adial Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
| 2018 | Adial Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
| 2017 | Adial Pharmaceuticals Inc Registered Shs | - | - | USD |
| 2016 | Adial Pharmaceuticals Inc Registered Shs | - | - | USD |
| 2015 | Adial Pharmaceuticals Inc Registered Shs | - | - | USD |
Zu diesem Datensatz liegen uns leider keine Daten vor.
Adial Pharmaceuticals Inc Registered Shs Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Adial Pharmaceuticals Inc Registered Shs | Quartalszahlen | 27.03.2025 |
| Adial Pharmaceuticals Inc Registered Shs | Quartalszahlen | 20.05.2025 |
| Adial Pharmaceuticals Inc Registered Shs | Quartalszahlen | 13.08.2025 |
| Adial Pharmaceuticals Inc Registered Shs | Quartalszahlen | 18.11.2025 |
Adial Pharmaceuticals Inc Registered Shs vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2024 Earnings Release | 13.11.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 14.08.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 15.05.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 02.04.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 14.11.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 12.05.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 30.03.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 14.11.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 16.08.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 16.05.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 98.25 |
| Armistice Capital LLC | 5.25 |
| Vanguard Total Stock Market ETF | 4.30 |
| Vanguard Group, Inc. (Subfiler) | 3.17 |
| Armistice Capital LLC | 2.48 |
| Susquehanna Securities LLC | 2.15 |
| Cary J. Claiborne, MBA | 0.95 |
| State Street Corp. | 0.82 |
| William B. Stilley, MBA | 0.79 |
| Manchester Capital Management LLC | 0.75 |
| Geode Capital Management LLC | 0.71 |
| Commonwealth Equity Services LLC | 0.57 |
| Fidelity Extended Market Index Fund | 0.55 |
| Renaissance Technologies LLC | 0.54 |
| Truist Bank | 0.53 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 4 | 9 | 18 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bilanz (in Mio. USD) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 0 | 5 | 8 | 5 | 6 |
| Summe Anlagevermögen | 0 | 0 | 0 | 0 | 1 |
| Summe Aktiva | 0 | 5 | 8 | 5 | 8 |
Bilanz (in Mio. USD) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 1 | 0 | 1 | 2 | 4 |
| Summe Eigenkapital | -1 | 4 | 7 | 4 | 4 |
| Summe Passiva | 0 | 5 | 8 | 5 | 8 |